[go: up one dir, main page]

DK1021204T3 - Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler - Google Patents

Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler

Info

Publication number
DK1021204T3
DK1021204T3 DK98949505T DK98949505T DK1021204T3 DK 1021204 T3 DK1021204 T3 DK 1021204T3 DK 98949505 T DK98949505 T DK 98949505T DK 98949505 T DK98949505 T DK 98949505T DK 1021204 T3 DK1021204 T3 DK 1021204T3
Authority
DK
Denmark
Prior art keywords
methods
bioadhesive
active agents
composition
topical administration
Prior art date
Application number
DK98949505T
Other languages
Danish (da)
English (en)
Inventor
Juan Mantelle
David Houze
David Kanios
Original Assignee
Noven Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22033995&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1021204(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Noven Pharma filed Critical Noven Pharma
Application granted granted Critical
Publication of DK1021204T3 publication Critical patent/DK1021204T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/043—Mixtures of macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/08—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/602—Type of release, e.g. controlled, sustained, slow
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings
    • A61L2300/608—Coatings having two or more layers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Surgery (AREA)
  • Nutrition Science (AREA)
  • Materials Engineering (AREA)
  • Physiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
DK98949505T 1997-09-26 1998-09-25 Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler DK1021204T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US6115597P 1997-09-26 1997-09-26

Publications (1)

Publication Number Publication Date
DK1021204T3 true DK1021204T3 (da) 2006-05-08

Family

ID=22033995

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98949505T DK1021204T3 (da) 1997-09-26 1998-09-25 Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler

Country Status (14)

Country Link
US (1) US6562363B1 (fr)
EP (1) EP1021204B1 (fr)
JP (1) JP2001517493A (fr)
AT (1) ATE314092T1 (fr)
AU (1) AU750809B2 (fr)
CA (1) CA2304958C (fr)
DE (1) DE69833000T2 (fr)
DK (1) DK1021204T3 (fr)
ES (1) ES2252865T3 (fr)
IL (1) IL135258A0 (fr)
NO (1) NO328846B1 (fr)
NZ (1) NZ504108A (fr)
RU (1) RU2234337C2 (fr)
WO (1) WO1999015210A2 (fr)

Families Citing this family (297)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
EP0965278A1 (fr) * 1998-06-16 1999-12-22 Mathias Christian Zohoungbogbo Produit alimentaire diététique et procédé diététique utilisant ce produit alimentaire
US6699497B1 (en) 1998-07-24 2004-03-02 Alza Corporation Formulations for the transdermal administration of fenoldopam
AU5105699A (en) * 1998-07-24 2000-02-14 Alza Corporation Formulations for the transdermal administration of fenoldopam
DE69941629D1 (de) 1998-12-18 2009-12-17 Alza Corp Durchsichtige transdermale nicotinabgabevorrichtungen
US20030170195A1 (en) * 2000-01-10 2003-09-11 Noven Pharmaceuticals, Inc. Compositions and methods for drug delivery
ES2237415T5 (es) * 1999-01-14 2008-12-16 Noven Pharmaceuticals, Inc. Composiciones dermicas.
DE60045211D1 (de) 1999-02-19 2010-12-23 Takeda Pharmaceutical Präparationen zur perkutanen aufnahme von zusammnesetzungen die einen angiotensin-ii-rezeptorantagonismus aufweisen
US8895064B2 (en) 1999-06-14 2014-11-25 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
DK1183014T3 (da) 1999-06-14 2004-02-09 Cosmo Spa Smagsmaskerede orale farmaceutiske sammensætninger med kontrolleret frigivelse
US20030158111A1 (en) * 1999-10-01 2003-08-21 David Bar-Or Methods and products for oral care
US7592304B2 (en) * 1999-10-01 2009-09-22 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US7632803B2 (en) 1999-10-01 2009-12-15 Dmi Life Sciences, Inc. Metal-binding compounds and uses therefor
US6383511B1 (en) 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
US6337076B1 (en) * 1999-11-17 2002-01-08 Sg Licensing Corporation Method and composition for the treatment of scars
DE19960154A1 (de) * 1999-12-14 2001-07-12 Lohmann Therapie Syst Lts Flache Arzneizubereitung zur transmucosalen Verabreichung von Oxycodon oder einem vergleichbaren Wirkstoff in der Mundhöhle, für die Anwendung in der Schmerztherapie und Suchttherapie
US7018647B1 (en) * 1999-12-27 2006-03-28 Teikoku Seiyaku Co., Ltd Patches for external use
WO2004087227A1 (fr) * 2003-04-04 2004-10-14 Tissuemed Limited Formulations pour adhesifs tissulaires
US7179483B2 (en) * 2000-04-26 2007-02-20 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
US20030124177A1 (en) * 2000-04-26 2003-07-03 Watson Pharmaceuticals, Inc. Compositions and methods for transdermal oxybutynin therapy
KR100338327B1 (ko) * 2000-05-16 2002-08-07 주식회사 태평양 피부 외용제 내의 활성성분의 피부 흡수를 증진시킬 수있는 조성물
KR100452972B1 (ko) * 2000-05-16 2004-10-14 주식회사 삼양사 경피투여용 하이드로젤 조성물
DE10025970C2 (de) * 2000-05-25 2002-04-25 Lohmann Therapie Syst Lts Estrogenhaltiges Pflaster mit einem Wirkstoffreservoir auf der Basis von Ethylcellulose und einem Ethylen-Vinylacetat-Vinylpyrrolidon-Copolymer und seine Verwendung
US20020013331A1 (en) * 2000-06-26 2002-01-31 Williams Robert O. Methods and compositions for treating pain of the mucous membrane
USRE44145E1 (en) 2000-07-07 2013-04-09 A.V. Topchiev Institute Of Petrochemical Synthesis Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
ES2240491T3 (es) * 2000-08-01 2005-10-16 Sanofi-Aventis Composicion farmaceutica para la administracion transdermica de befloxatona.
DE10041478A1 (de) 2000-08-24 2002-03-14 Sanol Arznei Schwarz Gmbh Neue pharmazeutische Zusammensetzung
AU2001282617A1 (en) * 2000-10-16 2002-04-29 Hisamitsu Pharmaceutical Co. Inc. Compositions for external preparations
US20030045539A1 (en) * 2000-11-06 2003-03-06 Baltazar Gomez-Mancilla Cabergoline and pramipexole: new uses and combinations
JP3962684B2 (ja) * 2000-11-06 2007-08-22 サムヤン コーポレイション 改善された水分吸収能および接着性を有する経皮投与剤
US7803392B2 (en) * 2000-12-27 2010-09-28 University Of Kentucky Research Foundation pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules
CA2434254C (fr) * 2001-01-12 2013-08-13 Board Of Regents, The University Of Texas System Nouveaux derives antiseptiques antimicrobiens a large spectre destines a l'impregnation de surfaces
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US20050215727A1 (en) * 2001-05-01 2005-09-29 Corium Water-absorbent adhesive compositions and associated methods of manufacture and use
US8541021B2 (en) 2001-05-01 2013-09-24 A.V. Topchiev Institute Of Petrochemical Synthesis Hydrogel compositions demonstrating phase separation on contact with aqueous media
US8206738B2 (en) * 2001-05-01 2012-06-26 Corium International, Inc. Hydrogel compositions with an erodible backing member
US8840918B2 (en) * 2001-05-01 2014-09-23 A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences Hydrogel compositions for tooth whitening
US20050113510A1 (en) * 2001-05-01 2005-05-26 Feldstein Mikhail M. Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
EP1390085B1 (fr) * 2001-05-01 2009-08-05 A.V. Topchiev Institute of Petrochemical Synthesis Compositions d'hydrogel
ATE502657T1 (de) * 2001-05-01 2011-04-15 Av Topchiev Inst Petrochemical Zweiphasige, wasserabsorbierende bioadhäsive zusammenstezung
WO2002094179A2 (fr) * 2001-05-23 2002-11-28 J.B. Chemicals & Pharmaceuticals Ltd. Nouvelles compositions microbicides topiques
EP1262172A1 (fr) * 2001-05-25 2002-12-04 Italmed S.N.C. Di Galli G. & Pacini G. Composition polymère liquide pour prevenir et traiter des maladies de la cavité orale
DE60236084D1 (de) * 2001-05-31 2010-06-02 Hisamitsu Pharmaceutical Co Perkutan resorbierbare pflaster
JP4943597B2 (ja) * 2001-07-31 2012-05-30 川澄化学工業株式会社 抗血栓性医療用具
US8425892B2 (en) 2001-10-29 2013-04-23 Columbia Laboratories, Inc. Extended, controlled-release pharmaceutical compositions using charged polymers
US20030114394A1 (en) * 2001-10-29 2003-06-19 Levine Howard L. Vaginally administered anti-dysrhythmic agents for treating pelvic pain
JP2005531557A (ja) * 2002-05-17 2005-10-20 メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング 選択的オピエート受容体モジュレーターとして効果的な化合物の使用
DE10226494A1 (de) * 2002-06-14 2004-01-08 Lts Lohmann Therapie-Systeme Ag Filmförmige mucoadhäsive Darreichungsformen zur Verabreichung von Cannabis-Wirkstoffen
WO2004018741A1 (fr) * 2002-08-23 2004-03-04 University Of Maryland Biotechnology Institute Depot de chitosane a la surface d'une electrode
US20050100515A1 (en) * 2002-09-11 2005-05-12 The Procter & Gamble Company Tooth whitening products
WO2004029096A2 (fr) * 2002-09-26 2004-04-08 University Of Maryland Biotechnology Institute Polymeres a base de polysaccharide et procedes de fabrication correspondants
US7166641B2 (en) * 2002-10-02 2007-01-23 Yung Shin Pharmaceutical Industrial Co., Ltd. Pharmaceutically acceptable salts containing local anesthetic and anti-inflammatory activities and methods for preparing the same
ITMI20022271A1 (it) * 2002-10-25 2004-04-26 Farmaka Srl Composizioni farmaceutiche bioadesive a base di anitiinfiammatori non steroidei.
WO2004041240A1 (fr) * 2002-11-05 2004-05-21 Piero Chiarelli Delivrance continue et regulee de rifaximine et/ou d'autres substances
US8250698B2 (en) * 2002-11-09 2012-08-28 Gavney Jr James A Hybrid cleaning device including absorbent and contact elements
US7790010B2 (en) * 2002-12-20 2010-09-07 University Of Maryland, College Park Spatially selective deposition of polysaccharide layer onto patterned template
US7883615B2 (en) * 2003-02-12 2011-02-08 University Of Maryland, College Park Controlled electrochemical deposition of polysaccharide films and hydrogels, and materials formed therefrom
BRPI0410505A (pt) * 2003-05-07 2006-06-20 Dmi Biosciences Inc métodos e produtos para cuidados orais
WO2004112723A2 (fr) * 2003-06-20 2004-12-29 Ronald Aung-Din Therapie locale pour le traitement des migraines, des claquages musculaires, des spasmes musculaires, de la spasticite et d'etats apparentes
US7250475B2 (en) * 2003-06-26 2007-07-31 Symyx Technologies, Inc. Synthesis of photoresist polymers
DE10334188B4 (de) 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
CA2534924A1 (fr) * 2003-08-08 2005-02-24 Elan Pharma International Ltd. Nouvelles compositions de metaxalone
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
WO2005025549A2 (fr) * 2003-09-10 2005-03-24 Noven Pharmaceuticals, Inc. Dispositif multicouche d'administration transdermique de medicaments
TW200512013A (en) * 2003-09-18 2005-04-01 Orient Europharma Co Ltd Gel formulation of oxybutynin hydrochloride
WO2005027864A1 (fr) * 2003-09-19 2005-03-31 Symyx Technologies, Inc. Materiaux conçus pour une meilleure administration d'agents actifs hydrophiles dans des preparations de soins personnels
NZ546992A (en) * 2003-10-28 2009-07-31 Noven Pharma Transdermal drug delivery device
DE10352602A1 (de) * 2003-11-11 2005-06-02 Rovi Gmbh & Co. Kosmetische Rohstoffe Kg Kosmetisches oder therapeutisches Kombinationspräparat
US20100330143A1 (en) 2003-12-04 2010-12-30 University Of Utah Research Foundation Modified macromolecules and methods of making and using thereof
CA2549295C (fr) 2003-12-04 2016-05-03 University Of Utah Research Foundation Macromolecules modifiees et procedes de production et d'utilisation associes
US7375404B2 (en) * 2003-12-05 2008-05-20 University Of Maryland Biotechnology Institute Fabrication and integration of polymeric bioMEMS
US20050132466A1 (en) * 2003-12-11 2005-06-23 Kimberly-Clark Worldwide, Inc. Elastomeric glove coating
US20050127552A1 (en) 2003-12-11 2005-06-16 Kimberly-Clark Worldwide, Inc. Method for forming an elastomeric article
FR2863502B1 (fr) * 2003-12-15 2007-03-16 Cousin Biotech Implant textile adhesif de refection parietale
DE50305977D1 (de) * 2003-12-22 2007-01-25 Scheuten Glasgroep Bv Verfahren zur Behandlung von Pulverkörner
CA2552911A1 (fr) * 2004-01-20 2005-08-11 Board Of Regents, The University Of Texas System Procedes de revetement et d'impregnation de dispositifs medicaux au moyen de compositions antiseptiques
CN102764247B (zh) 2004-01-30 2016-04-20 考里安国际公司 递送活性剂的快速溶解膜
IL160936A0 (en) * 2004-02-05 2004-08-31 Scott A Cordray Nasal spray and wash
US20050196355A1 (en) * 2004-03-03 2005-09-08 Constantine Georgiades Film products having controlled disintegration properties
US20050196348A1 (en) * 2004-03-03 2005-09-08 Constantine Georgiades Stabilized peroxide compositions
US20070190125A1 (en) * 2004-03-03 2007-08-16 Constantine Georgiades Positioning feature for aiding use of film or strip product
US20080003248A1 (en) * 2004-03-03 2008-01-03 Constantine Georgiades Whitening products
US20050196354A1 (en) * 2004-03-03 2005-09-08 Andre Soshinsky Film compositions
US20070269519A1 (en) * 2004-03-03 2007-11-22 Constantine Georgiades Whitening products
WO2005094210A2 (fr) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Formulations anthelmintiques a actions multiples
EP1740162A4 (fr) * 2004-04-29 2009-11-18 Caldwell Galer Inc Compositions de methadone topiques et procedes pour les utiliser
US20070196457A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070196452A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Flux-enabling compositions and methods for dermal delivery of drugs
US20070196325A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for dermally treating infections
US20070196293A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Compositions and methods for treating photo damaged skin
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8907153B2 (en) 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070190124A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Two or more solidifying agent-containing compositions and methods for dermal delivery of drugs
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070189980A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Compositions and methods for treating alopecia
US20080019927A1 (en) * 2004-06-07 2008-01-24 Jie Zhang Compositions and methods for dermally treating neuropathy with minoxidil
US20070196323A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Polyvinyl alcohol-containing compositions and methods for dermal delivery of drugs
US20070189978A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Compositions and methods for dermally treating musculoskeletal pain
US20070189977A1 (en) * 2004-06-07 2007-08-16 Jie Zhang Spray-on formulations and methods for dermal delivery of drugs
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8158139B2 (en) * 2004-07-12 2012-04-17 Taro Pharmaceuticals North America, Inc. Topical gel formulation comprising organophosphate insecticide and preparation thereof
WO2006017263A1 (fr) * 2004-07-12 2006-02-16 Taro Pharmaceutical Industries Ltd. Formulation d’un gel local comprenant un insecticide à base de phosphate organique et sa préparation
GB0416861D0 (en) * 2004-07-29 2004-09-01 Quadrant Drug Delivery Ltd Composition
ATE466566T1 (de) 2004-08-02 2010-05-15 Glaxo Group Ltd Neue zusammensetzung gegen xerostomie
WO2006013337A2 (fr) * 2004-08-03 2006-02-09 Tissuemed Limited Materiaux adhesifs tissulaires
WO2006017807A2 (fr) * 2004-08-05 2006-02-16 Corium International, Inc. Composition d'adhesif
US20070264319A1 (en) * 2004-09-01 2007-11-15 Lebo David B Transdermal Antiemesis Delivery System, Method and Composition Therefor
RU2272626C1 (ru) * 2004-09-06 2006-03-27 Открытое акционерное общество "Щелковский витаминный завод" Антипротозойное средство на основе метронидазола
RU2277933C2 (ru) * 2004-09-21 2006-06-20 Государственное образовательное учреждение высшего профессионального образования Курский государственный медицинский университет Министерства здравоохранения Российской Федерации Иммобилизованная форма цефазолина для профилактики послеоперационных инфекционных осложнений в оториноларингологии
US8246976B2 (en) * 2004-10-08 2012-08-21 Noven Pharmaceuticals, Inc. Transdermal delivery of drugs based on crystal size
WO2006041911A2 (fr) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Dispositif d'administration transdermique de medicaments contenant des polymeres acryliques
MX2007004315A (es) * 2004-10-08 2008-03-11 Noven Pharma Dispositivo para suministro transdermico de farmaco que incluye un respaldo oclusivo.
WO2006041907A2 (fr) 2004-10-08 2006-04-20 Noven Pharmaceuticals, Inc. Compositions et procedes d'administration d'oestradiol dans des systemes d'administration transdermiques de medicaments
RU2260432C1 (ru) * 2004-10-12 2005-09-20 Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм") Средство для лечения болезней суставов
EP1923059A1 (fr) * 2004-11-04 2008-05-21 BIOFARMITALIA S.p.A. Timbre contenant une substance sélectionnée parmi des goudrons ayant des caractéristiques réductrices en dermatologie
ITMI20042111A1 (it) * 2004-11-04 2005-02-04 Biofarmitalia Spa Cerotto contenenti una sostanza scelta tra i catrami aventi caratteristiche riducenti in dermatologia
FI20041425A0 (fi) 2004-11-05 2004-11-05 Orion Corp Transmukosaalinen veterinäärinen koostumus
US20060106117A1 (en) * 2004-11-12 2006-05-18 Kimberly-Clark Worldwide, Inc. Compound and method for prevention and/or treatment of vaginal infections
US7619008B2 (en) * 2004-11-12 2009-11-17 Kimberly-Clark Worldwide, Inc. Xylitol for treatment of vaginal infections
US8569367B2 (en) 2004-11-16 2013-10-29 Allergan, Inc. Ophthalmic compositions and methods for treating eyes
US7582330B2 (en) * 2004-11-24 2009-09-01 3M Innovative Properties Counsel Method for making metallic nanostructures
US20060110540A1 (en) * 2004-11-24 2006-05-25 3M Innovative Properties Company Method for making nanostructured surfaces
US7687115B2 (en) * 2004-11-24 2010-03-30 3M Innovative Properties Company Method for making nanostructured surfaces
US20060115785A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for intra-oral drug delivery
US7766658B2 (en) * 2004-11-30 2010-08-03 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US20060115782A1 (en) * 2004-11-30 2006-06-01 Chunhua Li Systems and methods for coating a dental appliance
US7947508B2 (en) * 2004-11-30 2011-05-24 Align Technology, Inc. Systems and methods for intra-oral diagnosis
US20060275230A1 (en) 2004-12-10 2006-12-07 Frank Kochinke Compositions and methods for treating conditions of the nail unit
MX2007006833A (es) 2004-12-10 2007-10-08 Talima Therapeutics Inc Composiciones y metodos para tratar condiciones de la unidad de una.
RU2277411C1 (ru) * 2004-12-15 2006-06-10 Ольга Алексеевна Кост Фармацевтическая композиция для лечения глазных болезней, связанных с нарушением микроциркуляции и/или воспалительными процессами
US8080560B2 (en) * 2004-12-17 2011-12-20 3M Innovative Properties Company Immune response modifier formulations containing oleic acid and methods
FR2879931B1 (fr) * 2004-12-24 2007-03-30 Rhodia Chimie Sa Materiau silicone pour la liberation d'une molecule active
RU2282443C1 (ru) * 2004-12-29 2006-08-27 Закрытое акционерное общество "Фармацевтическое предприятие "Оболенское" Лекарственное средство, обладающее антигипертензивным действием, и способ его изготовления
US20060213815A1 (en) * 2005-01-28 2006-09-28 Wille John J Hydrocarbon fume suppression by higher vapor pressure temperature oils
RU2283089C1 (ru) * 2005-03-03 2006-09-10 Общество с ограниченной ответственностью "Фарм-Лад" Мазь для наружного применения
EP1863469B1 (fr) 2005-03-15 2011-12-21 Animal Ethics Pty Ltd Composition analgesique locale
RU2357753C1 (ru) * 2005-03-24 2009-06-10 Владимир Николаевич Филатов Материал, обладающий биологической активностью, способ его получения и терапевтическое средство на его основе
US20060223765A1 (en) * 2005-03-30 2006-10-05 Kimberly-Clark Worldwide, Inc. Method for inhibiting and/or treating vaginal infection
AP2244A (en) * 2005-04-26 2011-06-24 Caldwell Galer Inc Topical methadone compositions and methods for using the same.
ITBO20050388A1 (it) * 2005-06-06 2006-12-07 Alfa Wassermann Spa Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
ATE415153T1 (de) * 2005-06-06 2008-12-15 Nitto Denko Corp Pharmazeutische zusammensetzung zur perkutane absorption unter verwendung von einem metalchlorid, vorzugsweise natriumchlorid, zur vorbeugung von kohäsionsschwäche
WO2006135491A2 (fr) 2005-06-08 2006-12-21 Basf Aktiengesellschaft Composition de porteur de medicament du procede de formation de film de la partir de cette composition
US20070082048A1 (en) * 2005-06-08 2007-04-12 Ronald Warner Sleep aid formulations
US7560445B2 (en) * 2005-07-06 2009-07-14 Taro Pharmaceuticals North America, Inc. Process for preparing malathion for pharmaceutical use
HUE036189T2 (hu) * 2005-07-28 2018-06-28 Academisch Ziekenhuis Bij De Univ Van Amsterdam Monofenol, benzoldiol vagy szulfhidril vegyületek melanómák kezelésében való alkalmazásra
US7786176B2 (en) 2005-07-29 2010-08-31 Kimberly-Clark Worldwide, Inc. Vaginal treatment composition containing xylitol
JP5058531B2 (ja) * 2005-09-09 2012-10-24 日東電工株式会社 ビソプロロール含有貼付製剤
US7718716B2 (en) * 2005-10-14 2010-05-18 3M Innovative Properties Company Chromonic nanoparticles containing bioactive compounds
US7629027B2 (en) 2005-10-14 2009-12-08 3M Innovative Properties Company Method for making chromonic nanoparticles
US20070092454A1 (en) * 2005-10-24 2007-04-26 Colgate-Palmolive Company Oral composition containing morin
US8119162B2 (en) 2005-11-10 2012-02-21 Colgate-Palmolive Company Particles that disrupt or impede bacterial adhesion, related compositions and methods
US8679545B2 (en) 2005-11-12 2014-03-25 The Regents Of The University Of California Topical corticosteroids for the treatment of inflammatory diseases of the gastrointestinal tract
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US8324192B2 (en) 2005-11-12 2012-12-04 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
US7807661B2 (en) * 2005-12-08 2010-10-05 3M Innovative Properties Company Silver ion releasing articles and methods of manufacture
US8071125B2 (en) * 2005-12-09 2011-12-06 Beijing Kangbeide Pharmaceutical Technology Development Co., Ltd. Transdermal patch containing isosorbide dinitrate and bisoprolol
EP1968539A2 (fr) 2005-12-13 2008-09-17 Biodelivery Sciences International, Inc. Dispositif resistant aux abus pour l'administration transmucosale de medicaments
CA2633515C (fr) * 2005-12-14 2011-10-18 Jie Zhang Compositions et procedes pour le traitement dermique de la douleur
CN102670567A (zh) * 2005-12-14 2012-09-19 扎尔斯制药公司 用于皮肤输送药物的促通量组合物及方法
CA2747845C (fr) * 2005-12-14 2012-10-09 Zars Pharma, Inc. Compositions et procedes pour le traitement dermique de la douleur
CN101370453B (zh) * 2005-12-14 2013-12-18 努沃研究公司 用于皮肤输送药物的组合物和方法
US7601769B2 (en) * 2005-12-19 2009-10-13 3M Innovative Peroperties Company Multilayered chromonic structures
US8092710B2 (en) * 2005-12-19 2012-01-10 3M Innovative Properties Company Hierarchical chromonic structures
US7541052B1 (en) * 2005-12-23 2009-06-02 Scott Cordray Hypertonic solutions and method of treatment
US7824732B2 (en) * 2005-12-28 2010-11-02 3M Innovative Properties Company Encapsulated chromonic particles
US20070166244A1 (en) * 2006-01-19 2007-07-19 The Procter & Gamble Company Compositions comprising silicone pressure sensitive adhesives for delivering oral care substances
US8399012B2 (en) * 2006-04-17 2013-03-19 Kimberly-Clark Worldwide, Inc. Degradable therapeutic delivery device
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery
US20070259029A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water-dispersible patch containing an active agent for dermal delivery
US20070258935A1 (en) * 2006-05-08 2007-11-08 Mcentire Edward Enns Water dispersible films for delivery of active agents to the epidermis
US8703179B2 (en) * 2006-05-11 2014-04-22 Kimberly-Clark Worldwide, Inc. Mucosal formulation
RU2308966C1 (ru) * 2006-05-18 2007-10-27 Институт физиологически активных веществ Российской Академии Наук (ИФАВ РАН) Антиметастатическая композиция
TWI411451B (zh) * 2006-06-01 2013-10-11 Msd Consumer Care Inc 用於結腸吸收之脫羥腎上腺素醫藥調配物及組合物
CN101472561A (zh) * 2006-06-01 2009-07-01 先灵公司 去氧肾上腺素脉冲释放制剂和药物组合物
AR061166A1 (es) * 2006-06-01 2008-08-06 Schering Corp Composiciones farmaceuticas para la liberacion sostenida de fenilferina
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
TWI392670B (zh) * 2006-06-22 2013-04-11 Ucb Pharma Gmbh 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途
US7635415B2 (en) 2006-06-29 2009-12-22 The Clorox Company Regenerable cleaning implement for sanitizing a surface
RS54764B1 (sr) * 2006-07-21 2016-10-31 Biodelivery Sciences Int Inc Sredstvo za transmukozalnu isporuku sa povećanim nakupljanjem
RU2317810C1 (ru) * 2006-07-27 2008-02-27 Открытое Акционерное Общество "Татхимфармпрепараты" Состав и способ получения глазной мази ципрофлоксацина
EP1891946A1 (fr) * 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Administration transmuqueuse de la 2,3-diméthoxy-5-méthyl-6-(10-hydroxydecyl)-1,4-benzoquinone
US20080057090A1 (en) * 2006-09-01 2008-03-06 Mcentire Edward Enns Wrinkle masking film composition for skin
US7879942B2 (en) * 2006-10-05 2011-02-01 Eastman Chemical Company Switchable adhesive article for attachment to skin and method of using the same
JP2010508289A (ja) * 2006-10-27 2010-03-18 ノーヴェン ファーマシューティカルズ インコーポレイテッド ケトプロフェン極性誘導体の経皮的送達
US7976951B2 (en) 2006-11-14 2011-07-12 Momentive Performance Materials Inc. Laminate containing an adhesive-forming composition
US7829116B2 (en) * 2006-11-14 2010-11-09 Momentive Performance Materials Inc. Adhesive-forming composition and blend of adhesives obtained therefrom
RU2322232C1 (ru) * 2006-12-04 2008-04-20 Институт Молекулярной Генетики Российской Академии Наук (Имг Ран) Композиция для приготовления противотромбозного геля
WO2008069283A1 (fr) * 2006-12-06 2008-06-12 Nipro Patch Co., Ltd. Composition pharmaceutique pour application externe et timbre dermique adhesif
EP2097116B1 (fr) * 2006-12-22 2012-09-12 Laboratoire Medidom S.A. Système in situ pour une réparation du tissu chondral et osseux intra-articulaire
EP2123274B1 (fr) * 2007-03-02 2016-08-24 Teika Pharmaceutical Co., Ltd. Composition médicinale pour une absorption transdermique, unité de stockage de la composition médicinale et préparation par absorption transdermique utilisant celle-ci
DK2136801T3 (da) 2007-03-30 2012-12-17 Tioga Pharmaceuticals Inc Kappa-opiat-agonister til behandling af diarré-dominerende og afvekslende irritabel tarmsyndrom
US20080300322A1 (en) * 2007-06-01 2008-12-04 Atlantic Pharmaceuticals, Inc. Delivery vehicles containing rosin resins
WO2008150493A1 (fr) * 2007-06-01 2008-12-11 Schering-Plough Healthcare Products, Inc. Composition pharmaceutique comprenant un substrat et un revêtement contenant un ingrédient actif et un alcool polyvinylique
ITRM20070510A1 (it) * 2007-10-02 2009-04-03 Rmfa Trading S A Composizioni oftalmiche a base di polisaccaride del seme di tamarindo e acido ialuronico.
US20090143343A1 (en) * 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
US20100216754A1 (en) * 2007-11-13 2010-08-26 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
KR101245604B1 (ko) 2007-11-13 2013-03-21 메리테이지 파마, 인크. 코르티코스테로이드 조성물
US20090123551A1 (en) * 2007-11-13 2009-05-14 Meritage Pharma, Inc. Gastrointestinal delivery systems
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
US9314524B2 (en) * 2007-12-31 2016-04-19 Calla Therapeutics Llc Topical formulations of Flucytosine
US20090221615A1 (en) * 2008-02-29 2009-09-03 Guru Reddy Combination anti-cancer agents
RU2376016C1 (ru) * 2008-03-04 2009-12-20 Мария Станиславовна Коллерова Средство для лечения воспалительных заболеваний пародонта
EP2268268A2 (fr) 2008-03-24 2011-01-05 Wockhardt Research Centre Compositions orodispersibles de rhéine ou de diacéréine
US9072727B2 (en) * 2008-04-18 2015-07-07 Warsaw Orthopedic, Inc. Alpha adrenergic receptor agonists for treatment of degenerative disc disease
US20090264392A1 (en) * 2008-04-21 2009-10-22 Meritage Pharma, Inc. Treating eosinophilic esophagitis
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
EP2278999B1 (fr) 2008-04-21 2025-01-29 Dompé farmaceutici S.p.A. Préparations auriculaires de traitement de maladies et états otiques
WO2009132208A1 (fr) * 2008-04-24 2009-10-29 Evestra, Inc. Formes galéniques contraceptives orales renfermant un progestogène dispersé dans un polymère gastrorésistant et renfermant en outre un œstrogène
WO2009133128A1 (fr) * 2008-04-29 2009-11-05 Pharnext Compositions combinées destinées à traiter la maladie d’alzheimer et les troubles associés, au moyen de zonisamide et d’acamprosate
US8729108B2 (en) * 2008-06-17 2014-05-20 Christopher J Dannaker Waterborne topical compositions for the delivery of active ingredients such as azelaic acid
WO2010008863A1 (fr) * 2008-06-23 2010-01-21 Biodelivery Sciences International, Inc. Dispositifs d'administration mucosale à directions multiples et leurs procédés d'utilisation
KR20110025974A (ko) * 2008-06-25 2011-03-14 엔도 파마슈티컬즈, 솔루션스 아이엔씨. 이형제를 함유하는 옥트레오티드 이식물
US8231906B2 (en) 2008-07-10 2012-07-31 Noven Pharmaceuticals, Inc. Transdermal estrogen device and delivery
CN102105133B (zh) 2008-07-21 2015-06-17 奥德纳米有限公司 控制释放型耳结构调节和先天性免疫系统调节组合物以及治疗耳部病症的方法
US8784870B2 (en) * 2008-07-21 2014-07-22 Otonomy, Inc. Controlled release compositions for modulating free-radical induced damage and methods of use thereof
CN102176818A (zh) * 2008-08-12 2011-09-07 诺华贝制药公司 抗微生物凝胶制剂
LT2328553T (lt) 2008-08-20 2020-09-10 The Regents Of The University Of California Kortikosteroidai, skirti virškinimo trakto uždegiminių ligų gydymui
CA2735418A1 (fr) * 2008-08-26 2010-03-11 Ray L. Hauser Administration de substance a la peau et autres tissus
US20100120776A1 (en) * 2008-11-12 2010-05-13 Hall Bioscience Corporation Carbocysteine medical foods
US8945592B2 (en) * 2008-11-21 2015-02-03 Acelrx Pharmaceuticals, Inc. Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
AU2010204986B2 (en) 2009-01-14 2016-06-02 Corium International, Inc. Transdermal administration of tamsulosin
EP2391397A2 (fr) * 2009-02-02 2011-12-07 Medtronic, Inc. Accessoire antimicrobien composite comprenant une couche de membrane et une couche poreuse
US8858983B2 (en) * 2009-04-30 2014-10-14 Medtronic, Inc. Antioxidants and antimicrobial accessories including antioxidants
US8920392B2 (en) 2009-05-05 2014-12-30 Watson Laboratories, Inc. Method for treating overactive bladders and a device for storage and administration of topical oxybutynin compositions
WO2010144865A2 (fr) * 2009-06-12 2010-12-16 Meritage Pharma, Inc. Procédés de traitement de troubles gastro-intestinaux
US20090318568A1 (en) * 2009-08-26 2009-12-24 Hauser Ray L Adherent coating for tissue surface and/or trans-tissue surface substance delivery
WO2011042897A1 (fr) * 2009-10-05 2011-04-14 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd Compositions de précurseur liquide et leurs utilisations pour un traitement à libération entretenu dépendant du ph de troubles oraux
US8771693B2 (en) 2009-10-27 2014-07-08 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
RU2432964C2 (ru) * 2009-11-26 2011-11-10 Государственное образовательное учреждение высшего профессионального образования Кабардино-Балкарский государственный университет им. Х.М. Бербекова (КБГУ) Полимерная целлюлозная композиция и способ ее получения
RU2416394C1 (ru) * 2010-01-25 2011-04-20 Пшеничников Виталий Георгиевич Фармацевтическая композиция в виде спрея для лечения раневых поверхностей
CA2789895C (fr) 2010-03-08 2019-04-09 Spectrum Pharmaceuticals, Inc. Therapies utilisant un inhibiteur d'autophagie a base de thioxanthone pour traiter le cancer
US8952038B2 (en) 2010-03-26 2015-02-10 Philip Morris Usa Inc. Inhibition of undesired sensory effects by the compound camphor
JP2013523092A (ja) 2010-03-26 2013-06-17 フィリップ・モーリス・プロダクツ・ソシエテ・アノニム 非喫煙用タバコ製品の消費中の感覚刺激の抑制
US9572773B2 (en) * 2010-04-26 2017-02-21 Novartis A.G. Layered drug delivery device
WO2011139420A2 (fr) 2010-04-30 2011-11-10 Teikoku Pharma Usa, Inc. Compositions transdermiques de propynylaminoindane
WO2011162756A1 (fr) * 2010-06-23 2011-12-29 Colgate-Palmolive Company Composition thérapeutique orale
US8287901B2 (en) * 2010-08-11 2012-10-16 Adhezion Biomedical, Llc Wound healing compositions based on cyanoacrylates and 5,5-disubstitutedhydantoins, including phenytoin
CA2817982C (fr) 2010-11-15 2020-06-30 The Regents Of The University Of Michigan Systemes mucoadhesifs a liberation controlee
US8911427B2 (en) * 2010-12-28 2014-12-16 Medtronic, Inc. Therapeutic agent reservoir delivery system
WO2012122163A1 (fr) * 2011-03-07 2012-09-13 3M Innovative Properties Company Dispositifs et procédés de micro-aiguille
KR101853082B1 (ko) 2011-03-24 2018-04-27 테이코쿠 팔마 유에스에이, 인코포레이티드 활성제층 및 활성제 변환층을 포함하는 경피 조성물
WO2012149334A2 (fr) 2011-04-27 2012-11-01 Beth Israel Deaconess Medical Center, Inc. Procédés et compositions pour préparer et utiliser des anticorps spécifiques à une conformation
US11786455B2 (en) 2011-05-10 2023-10-17 Itochu Chemical Frontier Corporation Non-aqueous patch
ES3034911T3 (en) 2011-05-10 2025-08-26 Itochu Chemical Frontier Corp Non-aqueous patch
WO2012153396A1 (fr) * 2011-05-10 2012-11-15 伊藤忠ケミカルフロンティア株式会社 Timbre non aqueux
KR101593339B1 (ko) * 2011-06-20 2016-02-11 히사미쓰 세이야꾸 가부시키가이샤 리도카인 함유 파프제
WO2013010045A1 (fr) 2011-07-12 2013-01-17 Biotime Inc. Nouveaux procédés et formulations pour thérapie cellulaire orthopédique
JP6158810B2 (ja) 2011-08-18 2017-07-05 バイオデリバリー サイエンシズ インターナショナル，インコーポレーテッド ブプレノルフィンの乱用抵抗性粘膜付着性送達デバイス
US10154964B2 (en) 2011-09-07 2018-12-18 Cosmo Technologies Limited Controlled release and taste masking oral pharmaceutical composition
MX367430B (es) 2011-09-27 2019-07-11 Itochu Chemical Frontier Corp Parche no acuoso.
EP2776020B1 (fr) 2011-11-09 2019-09-11 Teikoku Seiyaku Co., Ltd. Méthodes pour le traitement de tumeurs de la peau
EP2594132A1 (fr) * 2011-11-16 2013-05-22 Lanxess Deutschland GmbH Stabilisation de composés contenant de l'iode avec des polymères contenant de l'azote
US9907826B2 (en) 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9901539B2 (en) 2011-12-21 2018-02-27 Biodelivery Sciences International, Inc. Transmucosal drug delivery devices for use in chronic pain relief
EP3673902B1 (fr) * 2012-02-19 2022-01-05 Quest Products, LLC Adhésif de gomme d'acacia alcalinisé pour disques d'adhérence orale
RU2492873C1 (ru) * 2012-10-19 2013-09-20 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Сорбционный материал для лечения ран и ожогов различной этиологии
RU2493877C1 (ru) * 2012-10-19 2013-09-27 Закрытое акционерное общество "ФИРН М" (ЗАО "ФИРН М") Ранозаживляющее медицинское средство для лечения ран и ожогов с терапевтическим эффектом
KR20150059177A (ko) 2012-11-02 2015-05-29 테이코쿠 팔마 유에스에이, 인코포레이티드 프로피닐아미노인단 경피 조성물
CN105209084B (zh) 2013-03-13 2018-07-03 艾利丹尼森公司 改善的粘合性能
US11337936B2 (en) 2013-03-14 2022-05-24 Noven Pharmaceuticals, Inc. Amphetamine transdermal compositions with acrylic block copolymer
AU2014241396A1 (en) 2013-03-14 2015-09-17 Hallux, Inc. Method of treating infections, diseases or disorders of nail unit
CN105764496B (zh) * 2013-10-07 2020-09-25 帝国制药美国公司 用于经皮递送非镇静量的右旋美托咪啶的方法和组合物
TWI704933B (zh) 2013-10-07 2020-09-21 美商帝國製藥美國股份有限公司 右美托咪啶經皮輸送裝置及使用其之方法
TWI709417B (zh) 2013-10-07 2020-11-11 美商帝國製藥美國股份有限公司 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物
RU2550916C1 (ru) * 2013-12-26 2015-05-20 Открытое Акционерное Общество "Татхимфармпрепараты" Фармацевтическая композиция для лечения заболеваний опорно-двигательного аппарата
FR3017533B1 (fr) * 2014-02-19 2016-03-11 Cousin Biotech Dispositif implantable, notamment pour la refection de paroi abdominale
RU2592370C9 (ru) * 2014-04-24 2016-08-27 Иван Иванович Дедов Средство на основе дегидроэпиандростерона, способ его применения
RU2560516C1 (ru) * 2014-07-21 2015-08-20 Федеральное государственное бюджетное научное учреждение "Всероссийский научно-исследовательский институт фундаментальной и прикладной паразитологии животных и растений имени К.И. Скрябина" (ФГБНУ "ВНИИП им. К.И. Скрябина) Антигельминтное средство с трематодоцидной и цестодоцидной активностью
CA2968611A1 (fr) 2014-11-25 2016-06-02 Trophea Development AB Traitement d'atrophie cutanee avec une combinaison d'acide triiodothyroacetique (triac) et de deshydroepiandrosterone (dhea)
WO2017019907A1 (fr) 2015-07-28 2017-02-02 Otonomy, Inc. Compositions d'agoniste trkb ou trkc et méthodes de traitement de troubles otiques
CA3033570C (fr) * 2015-08-17 2022-12-06 Sidmak Laboratories (India) Pvt. Ltd. Systeme d'administration de film par voie topique
RU2677338C2 (ru) * 2015-10-06 2019-01-16 Общество с ограниченной ответственностью "Трейдсервис" Лекарственная форма диоксотетрагидрокситетрагидронафталина
WO2018005830A1 (fr) 2016-06-29 2018-01-04 Otonomy, Inc. Formulations otiques à base de triglycérides et leurs utilisations
WO2018002673A1 (fr) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Nouvelles formulations d'antagonistes du récepteur de l'angiotensine ii
KR20180036580A (ko) * 2016-09-30 2018-04-09 주식회사 유스바이오팜 수가용화(水加溶化)된 우르소데옥시콜산을 함유하는 염증성 피부질환 또는 중증 소양증 예방 또는 치료용 조성물
DE102017104026A1 (de) 2017-02-27 2018-08-30 Lts Lohmann Therapie-Systeme Ag Nicotin enthaltendes transparentes transdermales therapeutisches System
EP3662905B1 (fr) 2017-08-01 2022-05-04 Hisamitsu Pharmaceutical Co., Inc. Pansement adhésif
DE102017127433A1 (de) 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag TTS auf Basis von klebenden Weichmacher-Polymer-Matrices
DE102017127452A1 (de) * 2017-11-21 2019-05-23 Lts Lohmann Therapie-Systeme Ag Wasserlösliche Polymerklebschichten
WO2019126166A1 (fr) 2017-12-22 2019-06-27 Noven Pharmaceuticals, Inc. Compositions pharmaceutiques transdermiques à irritation cutanée réduite
SMT202500279T1 (it) 2018-01-09 2025-09-12 Dompe Farm Spa Formulazioni del fattore di crescita auricolare
WO2019154895A1 (fr) 2018-02-08 2019-08-15 Strekin Ag Formulation en gel pour la prévention ou le traitement de la perte auditive
CA3097189A1 (fr) * 2018-04-25 2019-10-31 Shinkei Therapeutics Llc Dispositif d'administration transdermique de tetrabenazine
WO2020100096A1 (fr) * 2018-11-15 2020-05-22 Glenmark Specialty S.A. Composition topique comprenant de la mupirocine
ES2777899A1 (es) * 2019-02-06 2020-08-06 Hector Alfredo Duilio Polizzi Apósito oral con efecto anestésico
RU2770045C2 (ru) * 2020-04-16 2022-04-14 Андрей Анатольевич Сланевский Способ регенерации резины
CN111671737B (zh) * 2020-05-26 2022-07-08 浙江工业大学 一种地塞米松口腔速溶膜剂及其制备方法
US12491166B2 (en) 2020-08-31 2025-12-09 Wacker Chemie Ag Method of delivering an active compound and delivery device for use in the same
JP2024500060A (ja) 2020-12-07 2024-01-04 オーアンドエム ハリヤード インコーポレイテッド ダンプハンド着用の保湿用グローブ
RU2761303C1 (ru) * 2021-03-15 2021-12-07 Общество с ограниченной ответственностью "Дубна-Биофарм". Способ получения фармацевтической композиции и фармацевтическая композиция для лечения и профилактики заболеваний пародонта
CN113181418B (zh) * 2021-04-09 2022-05-03 青岛大学附属医院 一种医用粘合剂及其制备方法
WO2023062201A1 (fr) * 2021-10-15 2023-04-20 Lts Lohmann Therapie-Systeme Ag Système thérapeutique transdermique pour l'administration transdermique de tizanidine
IL315466A (en) * 2022-03-11 2024-11-01 Lts Lohmann Therapie Systeme Ag A transmucosal therapeutic system containing a macrolide immunosuppressant
CA3241999A1 (fr) * 2022-03-11 2023-09-14 Marlene Fuhrmann Systeme therapeutique oromucosal contenant une couche adhesive

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1050070A (fr) * 1900-01-01
SE352239B (fr) 1966-11-30 1972-12-27 Astra Pharma Prod
GB1430515A (en) 1973-09-04 1976-03-31 Hollister Inc Pharmaceutical preparations
GB2046773B (en) * 1979-03-21 1983-08-03 Advance Tapes Uk Ltd Gelatinous articles and compositions
DE2951319C2 (de) 1979-12-20 1983-12-22 Beiersdorf Ag, 2000 Hamburg Paste für medizinische Zwecke
JPS58213709A (ja) * 1982-06-05 1983-12-12 Teikoku Seiyaku Kk 歯肉粘膜用貼付剤
FR2532546B1 (fr) * 1982-09-07 1985-12-27 Biotrol Sa Lab Pate pour la protection de la peau
DE3580384D1 (de) * 1984-04-09 1990-12-13 Toyo Boseki Praeparat mit verzoegerter freigabe zum aufbringen auf die schleimhaeute der mundhoehle.
US4593053A (en) * 1984-12-07 1986-06-03 Medtronic, Inc. Hydrophilic pressure sensitive biomedical adhesive composition
US4755396A (en) 1984-12-10 1988-07-05 Geisler Thomas C Image receiving element for thermal printers
US4751087A (en) 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
US4764378A (en) 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
USRE33093E (en) 1986-06-16 1989-10-17 Johnson & Johnson Consumer Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
JPH0794384B2 (ja) 1986-09-01 1995-10-11 帝国製薬株式会社 徐放性口腔内用製剤
JPS63160661A (ja) 1986-12-24 1988-07-04 テルモ株式会社 外用組成物
US5656286A (en) * 1988-03-04 1997-08-12 Noven Pharmaceuticals, Inc. Solubility parameter based drug delivery system and method for altering drug saturation concentration
US5032207A (en) 1988-03-04 1991-07-16 Noven Pharmaceuticals, Inc. One-step method for forming a pressure-sensitive adhesive transdermal drug device
US5234957A (en) * 1991-02-27 1993-08-10 Noven Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5446070A (en) 1991-02-27 1995-08-29 Nover Pharmaceuticals, Inc. Compositions and methods for topical administration of pharmaceutically active agents
US5047244A (en) * 1988-06-03 1991-09-10 Watson Laboratories, Inc. Mucoadhesive carrier for delivery of therapeutical agent
JP3115625B2 (ja) 1991-03-30 2000-12-11 帝國製薬株式会社 リドカイン含有外用貼付剤
US5346701A (en) * 1993-02-22 1994-09-13 Theratech, Inc. Transmucosal delivery of macromolecular drugs
EP0717761A4 (fr) * 1993-08-19 1998-01-07 Cygnus Therapeutic Systems Auto-adhesif soluble dans l'eau adherant a une muqueuse et dispositifs servant a le positionner dans une cavite corporelle revetue d'une muqueuse
IL116539A (en) * 1995-01-06 2002-02-10 Noven Pharma Preparations given through the skin of unstable anti-acid drugs
US6210699B1 (en) 1999-04-01 2001-04-03 Watson Pharmaceuticals, Inc. Oral transmucosal delivery of drugs or any other ingredients via the inner buccal cavity

Also Published As

Publication number Publication date
EP1021204B1 (fr) 2005-12-28
WO1999015210A2 (fr) 1999-04-01
NZ504108A (en) 2002-06-28
NO328846B1 (no) 2010-05-31
JP2001517493A (ja) 2001-10-09
CA2304958A1 (fr) 1999-04-01
AU750809B2 (en) 2002-07-25
IL135258A0 (en) 2001-05-20
ES2252865T3 (es) 2006-05-16
NO20001567D0 (no) 2000-03-24
WO1999015210B1 (fr) 1999-08-19
RU2234337C2 (ru) 2004-08-20
US6562363B1 (en) 2003-05-13
DE69833000T2 (de) 2006-09-07
NO20001567L (no) 2000-05-25
EP1021204A2 (fr) 2000-07-26
CA2304958C (fr) 2008-12-30
AU9581398A (en) 1999-04-12
DE69833000D1 (de) 2006-02-02
WO1999015210A3 (fr) 1999-06-17
ATE314092T1 (de) 2006-01-15

Similar Documents

Publication Publication Date Title
DK1021204T3 (da) Bioadhæsive præparater og fremgangsmåder til topisk administration af aktive midler
DK0573576T3 (da) Midler til topisk administration af farmaceutisk aktive stoffer
AR002355A1 (es) Composiciones y metodos para administracion local de agentes farmaceuticamente activos.
DK1079806T3 (da) Præparater til påföringen af antiinflammatoriske, især antiseptiske midler og/eller midler, der fremmer helingen af sår, til de övre luftveje og/eller öret
MY129356A (en) Electrospun pharmaceutical compositions
ATE323473T1 (de) Pharmazeutische zusammensetzungen enthaltend resveratrol und verwendungen davon
ITMI961152A0 (it) Composizione terapeutica per la somministrazione transdermica di un principio attivo estrogeno o progestinico o di loro miscele
TR199901417T2 (xx) Analjezik etkisi olan yeni bile�imler.
EA200500149A1 (ru) Тканевые протективные цитокины для защиты, восстановления и стимуляции реактивных клеток, тканей и органов
PT918507E (pt) Formulacoes em aerossol
CA2326198A1 (fr) Formulations de cosolvants
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger
DK1303278T3 (da) Kombination af et transdermalt terapeutisk system og et oralt og/eller parenteralt præparat indeholdende dopaminagonister til behandling af dopaminerge sygdomme
CA2417935A1 (fr) Medicament anti-inflammatoire
TR200200473T2 (tr) Rar selektif retinoid agonistleri.
DK1300143T3 (da) Plaster som indeholder 4-biphenyleddikesyre
SE0001916D0 (sv) Novel formulation
TR200000005T2 (tr) Sıtmaya karşı ß-alkoksiakrilatlar.
IT1291895B1 (it) Preparazione farmaceutica fluida a base di nimesulide per uso orale e rinofaringeo
CO4370014A1 (es) Soluciones inyectables estables de diritromicina
IT1297139B1 (it) Composizioni per la somministrazione transdermica e dermica di sostanze biologicamente attive
ATE102934T1 (de) Fluorierte flavon-essigsaeure.